Pugatch Consilium represented at the World Justice Forum 2013, The Hague

Posted by:

The term ‘rule of law’ deals with the authority and influence of law in a society.  Yet for global businesses a burning question still requires insight: What does the rule of law and the wider legal environment mean for your company?

Dr David Torstensson, Senior Consultant at Pugatch Consilium, will be attending the World Justice Forum 2013 held this week in The Hague to discuss this and other related questions. He  will be presenting his preliminary findings on Thursday 11 July” ...

Continue Reading →
0

Breaking the European health financing taboo

Posted by:

How do we break the vicious circle of European healthcare financing? Europe has a changing demographic profile with more elderly people, more innovative new medicines and treatments, and greater consumer demand; at the same time, EU governments have less money to pay for healthcare. In a nutshell, we want what we cannot have.

On the surface, Europeans seem, a bit like the spoiled brat Veruca Salt from Charlie and the Chocolate Factory: they instinctively reject any healthcare reform which involves a ...

Continue Reading →
0

Monsanto and Myriad: deeper implications

Posted by:

When legal battles reach the Supreme Court, a fair amount of media scrutiny follows as the rulings often delve deeper into the inner meanings of the judges’ interpretations. The high-profile cases of Monsanto vs. Bowman and Myriad Genetics certainly did not go against this formula as they both brought to the forefront the issues of scope and threshold of patent protection respectively. In Monsanto, the Court upheld the principle in which the patent owner may set boundaries and limitations on ...

Continue Reading →
0

Prof. Pugatch keynote speech on the “Five megatrends in the pharmaceutical industry and its implications for emerging markets”

Posted by:

Prof. Pugatch keynote speech on the “five megatrends in the pharmaceutical industry and its implications for emerging markets”, at the 19th Annual International Russian Pharmaceutical Forum, St. Petersburg, 21-23 May 2013 http://www.adamsmithconferences.com/en/event/pharma-industry-russia

Continue Reading →
0

Pugatch Consilium at the World Creators Summit, June 4-5 2013 Washington DC

Posted by:

Dr David Torstensson, Senior Consultant with Pugatch Consilium, is attending the 2013 World Creators Summit in Washington DC, USA. Dr Torstensson is co-authoring a study of the creative economy in Brazil, Russia, India, China and South Africa commissioned by the International Confederation of Societies of Authors and Composers (CISAC) and is due for publication later this summer. He will be discussing the initial findings from this study at the World Creators Summit.

Dr Torstensson will be speaking on June 4th 2013 ...

Continue Reading →
0

Pugatch Consilium at BIO 2013 Chicago

Posted by:

Dr David Torstensson, Senior Consultant with Pugatch Consilium, is attending the 2013 BIO International Convention in Chicago, USA.

Dr Torstensson has been invited to speak on two panels.

Panel number 1, “The Compulsory Licensing Trend: Increased Access, or Lost Opportunities and Unintended Consequences?”, examines the economic, investment and access consequences of using compulsory licenses. Dr Torstensson will discuss the economic impact of the use of compulsory licensing focusing on the existing evidence and country examples. This event is scheduled for 2:30 PM ...

Continue Reading →
0

Pugatch Consilium featured in Public Service Europe

Posted by:

Public Service Europe has published an opinion piece by Professor Meir Pugatch, Managing Director of Pugatch Consilium, on the factors of Europe’s poor performance in conducting biopharmaceutical clinical trials compared to other developed countries.

The piece, published on 20 March 2013, features Pugatch Consilium research on global clinical trial activity and policy challenges in European countries with regards to the current environment for biopharmaceutical innovation.

To view the piece, see http://www.publicserviceeurope.com/article/3240/europe-faces-decline-in-clinical-trials-activity

Continue Reading →
0

Managing Director of Pugatch Consilium giving keynote presentation at the Russian Pharmaceutical Forum

Posted by:

Professor Meir Perez Pugatch, Managing Director and Founder of Pugatch Consilium, will open the 2013 Russian Pharmaceutical Forum on 21 May with the keynote presentation. Prof Pugatch will speak on “The changing nature of the pharmaceutical business and its implications for emerging markets”.

The Forum will place 21-23 May 2013 in St Petersburg.

For more details on the event, please see: http://www.adamsmithconferences.com/event/pharma-industry-russia

Continue Reading →
0

US State Department References GIPC-Pugatch Consilium International IP Index

Posted by:

Earlier this week the United States Department of State’s Bureau of Diplomatic Security released the India 2013 Crime and Safety Report.

The report, which details the crime and safety statistics and risks for American citizens and corporations in the New Delhi area, cites research conducted by Pugatch Consilium and the GIPC center of the US Chamber of Commerce on the intellectual property climate in India. The report refers to the fact that India ranked last in the 2012 edition of the ...

Continue Reading →
0

Dr David Torstensson, Pugatch Consilium Senior Consultant, speaking at US Chamber of Commerce event in Washington DC

Posted by:

The US Chamber of Commerce’s Global Intellectual Property Center (GIPC) is on Thursday February 21 2013 hosting a discussion of North American competiveness and innovation.

In addition to a key note speech by Ambassador John K. Veroneau the event will host a panel discussion on which Dr Torstensson will discuss the findings of the inaugural edition of the GIPC IP Index, a new cross-sectoral index of intellectual property rights authored by Pugatch Consilium and the GIPC.

For details of the event and ...

Continue Reading →
0
Page 9 of 15 «...7891011...»